Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
194
Employees194
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
194
Employees194

AKBA Key Statistics

Market cap
192.56M
Market cap192.56M
Price-Earnings ratio
-6.25
Price-Earnings ratio-6.25
Dividend yield
—
Dividend yield—
Average volume
7.84M
Average volume7.84M
High today
$0.7355
High today$0.7355
Low today
$0.4798
Low today$0.4798
Open price
$0.75
Open price$0.75
Volume
429.79K
Volume429.79K
52 Week high
$2.13
52 Week high$2.13
52 Week low
$0.4798
52 Week low$0.4798

Stock Snapshot

With a market cap of 192.56M, Akebia Therapeutics(AKBA) trades at $0.52. The stock has a price-to-earnings ratio of -6.25.

On 2026-11-05, Akebia Therapeutics(AKBA) stock moved within a range of $0.48 to $0.74. With shares now at $0.52, the stock is trading +7.3% above its intraday low and -30.0% below the session's peak.

Trading volume for Akebia Therapeutics(AKBA) stock has reached 429.79K, versus its average volume of 7.84M.

Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $2.13 and a low of $0.48.

Over the past 52 weeks, Akebia Therapeutics(AKBA) stock has traded between a high of $2.13 and a low of $0.48.

AKBA News

Simply Wall St 3d
Akebia Therapeutics (Nasdaq:AKBA) - Stock Analysis - Simply Wall St

...

Akebia Therapeutics (Nasdaq:AKBA) - Stock Analysis - Simply Wall St

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.